Esmo.org - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
100% 
Calidad de la página
47% 
Estructura
58% 
Enlazado
13% 
Servidor
100% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
0,05 s
Tamaño HTML
319,80 kB
Palabras
4014
Medios
21
Cantidad de enlaces
436 internos / 34 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
European Society for Medical Oncology
La longitud del título es óptima (355 píxeles de una longitud máxima de 580 píxeles).
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
ESMO is the European Society for Medical Oncology, providing a professional network for its members and working with national societies across Europe.
La longitud de la meta descripción es óptima (949 píxeles de una longitud máxima de 1000 píxeles).
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.esmo.org/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en-gb
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en-gb.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
copyrightESMO
authorESMO
keywordsmedical oncology,oncologists,oncology societies,oncology conferences,europe
descriptionESMO is the European Society for Medical Oncology, providing a professional network for its members and working with national societies across Europe.
generatoreZ Platform powered by Netgen
viewportwidth=device-width, initial-scale=1.0, maximum-scale=1
norton-safeweb-site-verificationn2ygvjh9mxjj82z9-mte778jumy0erkkd7zxsvx7ps8mpqx4avfdqnwqcw9dvfcmta5hjtjeya4vwcgxzq52gv3kdxnunzhimdkkks2zl39icco8x7d45ihmrkklqfc4
facebook-domain-verification3eeragwmlcd46ur5vkwb776r9jtxte
msvalidate.01BDC2955EF05146A4D0BC9BE3E6DF32BD
langen-gb
og:typewebsite
og:titleESMO
og:descriptionESMO
og:imagehttps://www.esmo.org/bundles/app/images/esmo_opengraph.png
charsetutf-8

¡Analiza ya gratis hasta 1.000 páginas de esmo.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
El contenido de esta página es demasiado extenso (4014 palabras). Tal vez podrías dividirlo en varias páginas según el tema.
Hay 6 textos duplicados en esta página:
  • Texto duplicado 1: Some initiatives show that collection and distribution of unused medic...
  • Texto duplicado 2: The ESMO Award for Immuno-Oncology 2024 is presented to Ton N. Schumac...
  • Texto duplicado 3: New indication concerns the treatment of patients with early breast ca...
La cantidad media de palabras por frase es elevada: 83.64 palabras.
Un 25.3% del contenido está constituido por palabras vacías.
Las palabras clave del título también se repiten en el texto del cuerpo.
Las palabras del encabezado H1 también aparecen en el cuerpo del texto.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 41 párrafos en esta página.
No se detecta ningún placeholder de texto ni imagen.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0, maximum-scale=1).
Etiquetas Bold y Strong
(Poco importante)
Algunas etiquetas de negritas son demasiado largas (más de 70 caracteres). Con 118 caracteres:
"oops, you're using an old version of your browser so some of the features on this page may not be disp...".
Optimización de imágenes
(Poco importante)
La descripción del atributo ALT se utiliza correctamente en todas las imágenes rastreadas.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
...age/30169140e251db563e46719de7ec91e4.svgESMO
...esmo-tat-2025-1000x250-abstracts_i30.jpgESMO-TAT-2025-1000x250-Abstracts
...795-3-eng-GB/esmo-mcbs-1000x1000_i30.jpgESMO-MCBS 1000x1000
...ients-with-the-best-care-options_i30.jpgProvide your patients with the best care options.
...es/4397014-1-eng-GB/esmo-courses_i30.jpgESMO Courses
...-1-eng-GB/esmo-oncology-journals_i30.jpgESMO Oncology Journals
...ns/4396970-1-eng-GB/publications_i30.jpgPublications
...773-1-eng-GB/emuc-2024-1000x1000_i30.jpgEMUC-2024-1000x1000
...ceptorship-lung-cancer-1000x1000_i30.jpgESMO-Preceptorship-Lung-Cancer-1000x1000
...-data-in-breast-cancer-1000x1000_i30.jpgESMO-Advanced-Course-on-Deep-Dive-in-CDK4/6-Inhibitors-Data-in-Breast-Cancer-1000x1000
...t-to-individualization-1000x1000_i30.jpgESMO-Advanced-Courses-on-Pancreatic-Cancer-From-Standard-Treatment-to-Individualization-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
...ptorship-breast-cancer-1000x1000_i30.jpgESMO-Preceptorship-Breast-Cancer-1000x1000
...torship-gastric-cancer-1000x1000_i30.jpgESMO-Preceptorship-Gastric-Cancer-1000x1000
...smo-asia-congress-2024-1000x1000_i30.jpgESMO-ASIA-Congress-2024-1000x1000
...ceptorship-lung-cancer-1000x1000_i30.jpgESMO-Preceptorship-Lung-Cancer-1000x1000
...o-immuno-oncology-2024-1000x1000_i30.jpgESMO-Immuno-Oncology-2024-1000x1000
...orship-prostate-cancer-1000x1000_i30.jpgESMO-Preceptorship-Prostate-Cancer-1000x1000
...esmo-workshop-1000x1000-specific_i30.jpgESMO-Workshop-1000x1000-specific
URL del VídeoAnchoAlto
https://www.youtube.com/embed/oWDfgE7gxY4770433

Estructura de la página

Encabezado H1
(Extremadamente importante)
European Society For Medical Oncology
El encabezado H1 es óptimo.
Encabezados
(Importante)
Algunos de los encabezados H se repiten dos veces.
Hay 94 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 European Society For Medical Oncology
H2 See you in Geneva or online
H2 ESMO Targeted Anticancer Therapies Congress 2025
H2 ESMO-MCBS
H2 Latest News
H2 Redispensing cancer medicines means caring for the environment
H2 Translating cancer genome insights into practical clinical tools
H2 Studies present a wider application of sequencing techniques for the treatment of cancer
H2 Liquid biopsies are quickly evolving beyond ctDNA, but technical challenges remain
H2 Data from molecular analyses unveil diverse resistance mechanisms to endocrine therapy in breast cancer
H2 Innovation is leading to a comprehensive ‘map’ of tumours
H2 Adjuvant immunotherapy continues to confirm its efficacy in melanoma
H2 The expanding toolbox for immuno-oncology
H2 A c-Met directed antibody-drug conjugate shows preliminary activity in a NSCLC cohort
H2 Patient Guide on Bone Health in Cancer Now Available Also in Hungarian
H2 Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients with Low to Intermediate Risk Localised Prostate Cancer
H2 ESMO Recommendations on Continuity of Care for Patients with Cancer Reflected in the New WHO Europe Strategy for Health Emergency Preparedness
H2 FDA Grants Traditional Approval for Selpercatinib for Medullary Thyroid Cancer with a RET Mutation
H2 ESMO Award for Immuno-Oncology 2024 Recipient Announced
H2 EMA Recommends Extension of Indications for Ribociclib to Include Use in Patients with Early Breast Cancer
H2 Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer
H2 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer
H2 Redispensing cancer medicines means caring for the environment Texto duplicado
H2 Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients with Low to Intermediate Risk Localised Prostate Cancer Texto duplicado
H2 FDA Grants Traditional Approval for Selpercatinib for Medullary Thyroid Cancer with a RET Mutation Texto duplicado
H2 EMA Recommends Extension of Indications for Ribociclib to Include Use in Patients with Early Breast Cancer Texto duplicado
H2 Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer Texto duplicado
H2 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Texto duplicado
H2 Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma
H2 FDA Approves Amivantamab-vmjw with Carboplatin and Pemetrexed for Non-Small Cell Lung Cancer with EGFR Exon 19 Deletions or L858R Mutations
H2 FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole Co-pack for Early High-Risk Breast Cancer
H2 Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic or Pancreatic Neuroendocrine Tumours
H2 Molecular Analysis for Precision Oncology Congress 2024 London, UK, 16-18 October
H2 Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers
H2 Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease
H2 From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing, the ESMO Congress 2024 Takes a Holistic View of Oncology
H2 ESMO 2024 Press Conference
H2 ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being within the Oncology Workforce
H2 Studies Provide First Evidence That Breastfeeding after Breast Cancer Is Safe
H2 ESMO Congress 2024 Barcelona, Spain, 13-17 September
H2 Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
H2 ESMO Award for Immuno-Oncology 2024 Recipient Announced Texto duplicado
H2 ESMO Congress 2024: Five Days of Science Dissemination and Education
H2 2024 ESMO Fellowship Awardees Announced
H2 ESMO Releases a New Framework to Assess the Tumour-Agnostic Potential of Cancer Therapies
H2 Recipients of the 2024 ESMO Society Awards
H2 ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
H2 ESMO Journals Have Maintained Strong Impact Factors
H2 New ESMO President 2027-2028 Elected
H2 Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
H2 Education
H2 Provide your patients with the best care options.
H2 ESMO Courses
H2 ESMO Oncology Journals
H2 Publications
H2 Next Meetings
H2 16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
H2 ESMO Preceptorship on Lung Cancer 2024: Paris
H2 ESMO Advanced Course on Breast Cancer: Filling the Gaps Following Progression on CDK4/6 in Hormone Receptor Positive HER2 Negative Advanced Breast Cancer 2024: Doha
H2 ESMO Advanced Course on Pancreatic Cancer: From Standard Treatment to Individualization 2024: Barcelona
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and Genitourinary Cancers 2024: Zurich
H2 ESMO Preceptorship on Breast Cancer 2024: Singapore
H2 ESMO Preceptorship on Gastric Cancer 2024: Singapore
H2 ESMO Asia Congress 2024
H2 ESMO Preceptorship on Non-Small-Cell and Small-Cell Lung Cancer 2024: Singapore
H2 ESMO Immuno-Oncology Congress 2024
H2 ESMO Preceptorship on Prostate Cancer 2024: Lugano
H2 ESMO Resilience Task Force Workshop: Leading For Better Mental Health, Well-being And Resilience Of The Oncology Workforce
H2 Video Gallery
H2 ESMO Immuno-Oncology 2024 Congress: an event to explore challenges and emerging trends in the field
H2 ESMO Sarcoma and Rare Cancers 2025: Unlock Opportunities - Submit your abstract
H2 ESMO Sarcoma and Rare Cancers 2025: Why you should submit your abstract
H2 ESMO Asia 2024 – Unveiling the programme highlights. Prof Hanneke van Laarhoven & Prof Nadia Harbeck
H2 Discover the unique experience of ESMO Asia 2024 – Prof. Herbert Loong
H2 MAP 2024: shaping the future of precision oncology
H2 ESMO Breast Cancer 2025: Invitation from Scientific Committee Co-Chairs
H2 ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region
H2 Why you should attend ESMO Asia 2024 - Prof. Long & Prof. van Laarhoven
H2 Why young oncologists should attend ESMO Asia 2024 - Prof. Lim
H2 ESMO Immuno-Oncology 2024: Experts in different tumour types explain the importance of this congress
H2 World renowned experts on why you should attend MAP 2024
H2 Career Development
H2 Improve your career path
H2 Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
H2 ESMO Examination
H2 Thinking of applying for an ESMO Oncology Fellowship?
H2 Become a Member
H3 Membership
H4 177
H4 40k +
H4 40+
H5 Legal
H5 Useful links
H5 Subscribe to ESMO newsletters
Hay demasiados enlaces internos (436) en esta página.
Algunos textos ancla son demasiado largos.
Algunos enlaces internos contienen parámetros dinámicos. Las URL internas no deberían contener parámetros dinámicos, salvo que estén marcadas como nofollow.
Algunos textos ancla se repiten más de una vez en varios enlaces.
Hay 1 links con un texto ancla que no es suficientemente relevante.
Hay demasiados enlaces externos (34) en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.google.com/chrome/Nueva ventana Externo Subdominio Google Chrome 24+
https://www.mozilla.org/en-US/...Nueva ventana Externo Subdominio Mozilla Firefox 20+
https://www.microsoft.com/en-u...Nueva ventana Externo Subdominio Internet Explorer 11
https://www.opera.com/downloadNueva ventana Externo Subdominio Opera 15–18
https://www.apple.com/safari/Nueva ventana Externo Subdominio Apple Safari 7
https://www.seamonkey-project....Nueva ventana Externo Subdominio SeaMonkey 2.15-2.23
https://www.esmo.org/Subdominio ESMO
/meeting-calendarSubdominio Meeting Calendar
https://oncologypro.esmo.org/Externo Subdominio OncologyPRO
/membership/join-esmoSubdominio Become a member
https://www.esmo.org/saml/loginLogin
https://www.esmo.org/Subdominio Texto duplicado IMG-ALT ESMO
A-TITLE ESMO
/membership/member-benefitsSubdominio Benefits of an ESMO Membership
https://www.esmo.org/about-esmoSubdominio Who we are
/about-esmo/how-we-workSubdominio How we work
/about-esmo/esmo-valuesSubdominio Our values
https://www.esmo.org/Subdominio Texto duplicado ESMO
/meeting-calendarSubdominio Texto duplicado Meeting Calendar
https://oncologypro.esmo.org/Externo Subdominio Texto duplicado OncologyPRO
https://www.esmo.org/about-esmoSubdominio About ESMO
A-TITLE About ESMO
/about-esmo/esmo-vision-2025Subdominio ESMO Vision 2025
/about-esmo/esmo-vision-2025/o...Subdominio One Oncology Community
/about-esmo/esmo-vision-2025/e...Subdominio Education for Life
/about-esmo/esmo-vision-2025/a...Subdominio Accessible Cancer Care
/about-esmo/esmo-missionSubdominio ESMO Mission
/about-esmo/esmo-valuesSubdominio ESMO Values
/about-esmo/awardsSubdominio Awards
/about-esmo/awards/esmo-award-...Subdominio ESMO Award Nominations
/about-esmo/awards/fellow-of-e...Subdominio Fellow of ESMO (FESMO)
/about-esmo/awards/fellow-of-e...Subdominio FESMO 2022
/about-esmo/awards/esmo-awardSubdominio ESMO Award
/about-esmo/awards/esmo-award-...Subdominio ESMO Award for Translational Research
/about-esmo/awards/esmo-women-...Subdominio ESMO Women for Oncology Award
/about-esmo/awards/esmo-lifeti...Subdominio ESMO Lifetime Achievement Award
/about-esmo/awards/esmo-breast...Subdominio ESMO Breast Cancer Award
/about-esmo/awards/heine-h.-ha...Subdominio Heine H. Hansen Award
/about-esmo/awards/esmo-award-...Subdominio ESMO Award for Immuno-Oncology
/about-esmo/awards/tat-honorar...Subdominio TAT Honorary Award
/about-esmo/organisational-str...Subdominio Organisational Structure
/about-esmo/organisational-str...Subdominio ESMO Council
/about-esmo/organisational-str...Subdominio Executive Board
/about-esmo/organisational-str...Subdominio Annals of Oncology Editorial Board
/about-esmo/organisational-str...Subdominio Audit Committee
/about-esmo/organisational-str...Subdominio Cancer Medicines Committee
/about-esmo/organisational-str...Subdominio Compliance Committee
/about-esmo/organisational-str...Subdominio Educational Committee
/about-esmo/organisational-str...Subdominio Adolescents and Young Adults Working Group
/about-esmo/organisational-str...Subdominio Designated Centres Working Group
/about-esmo/organisational-str...Subdominio Educational Publications Working Group
/about-esmo/organisational-str...Subdominio ESMO Faculty
/about-esmo/organisational-str...Subdominio ESMO SIOG Cancer in the Elderly Working Group
/about-esmo/organisational-str...Subdominio Examination & Accreditation Working Group
/about-esmo/organisational-str...Subdominio OncologyPRO Working Group
/about-esmo/organisational-str...Subdominio Practising Oncologists Working Group
/about-esmo/organisational-str...Subdominio Real World Data and Digital Health Working Group
/about-esmo/organisational-str...Subdominio Translational Research and Precision Medicine Working Group
/about-esmo/organisational-str...Subdominio Texto duplicado ESMO Faculty
/about-esmo/organisational-str...Subdominio ESMO Open Editorial Board
/about-esmo/organisational-str...Subdominio Guidelines Committee
/about-esmo/organisational-str...Subdominio ESMO-Magnitude of Clinical Benefit Scale Working Group
/about-esmo/organisational-str...Subdominio Major Achievements
/about-esmo/organisational-str...Subdominio IOTECH Editorial Board
/about-esmo/organisational-str...Subdominio Leadership Development Committee
/about-esmo/organisational-str...Subdominio Membership Committee
/about-esmo/organisational-str...Subdominio National Societies Committee
/about-esmo/organisational-str...Subdominio Nomination Committee
/about-esmo/organisational-str...Subdominio Communication Committee
/about-esmo/organisational-str...Subdominio Women for Oncology Committee
/about-esmo/organisational-str...Subdominio Young Oncologists Committee
/about-esmo/organisational-str...Subdominio Texto duplicado Major Achievements
/about-esmo/organisational-str...Subdominio ESMO Members: Get Involved
/about-esmo/organisational-str...Subdominio ESMO-MCBS Working Group - Open Call for New Members
/about-esmo/organisational-str...Subdominio Volunteer with ESMO
/about-esmo/organisational-str...Subdominio YOC Open Call for Members
/about-esmo/organisational-str...Subdominio ESMO Task Forces
/about-esmo/organisational-str...Subdominio ESMO Gender Medicine Task Force
/about-esmo/organisational-str...Subdominio Climate Change Task Force
/about-esmo/organisational-str...Subdominio Resilience Task Force
/about-esmo/organisational-str...Subdominio ESMO Clinical Research Observatory Task Force (ECRO)
/about-esmo/organisational-str...Subdominio ESMO Gastrointestinal Oncology Editorial Board
/about-esmo/how-we-workSubdominio Texto duplicado How we work
/about-esmo/how-we-work/declar...Subdominio Declaration of Interest
/about-esmo/how-we-work/declar...Subdominio EFPIA Disclosure Code
/about-esmo/how-we-work/esmo-e...Subdominio ESMO Presidential Election: 2027-2028
/about-esmo/how-we-work/esmo-e...Subdominio ESMO Elections FAQ
/about-esmo/how-we-work/esmo-s...Subdominio ESMO Structure
/about-esmo/how-we-work/code-o...Subdominio Code of Conduct
/about-esmo/how-we-work/esmo-a...Subdominio ESMO Annual Report
/about-esmo/how-we-work/esmo-f...Subdominio ESMO Funding
/about-esmo/how-we-work/esmo-f...Subdominio 2019 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2020 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2021 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2022 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2023 Funding Sources
/about-esmo/how-we-work/bylawsSubdominio ESMO Bylaws
/about-esmo/how-we-work/esmo-g...Subdominio General Assembly
/about-esmo/how-we-work/esmo-g...Subdominio Notice of the 2024 Ordinary Annual General Assembly Vote
/about-esmo/biographiesSubdominio Biographies
/about-esmo/careers-at-esmoSubdominio Careers at ESMO
/about-esmo/discover-esmo-jour...Subdominio Discover ESMO Journals
/about-esmo/discover-esmo-jour...Subdominio Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio About Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Open
/about-esmo/discover-esmo-jour...Subdominio Frequently Asked Questions
/about-esmo/discover-esmo-jour...Subdominio Immuno-Oncology and Technology
/about-esmo/discover-esmo-jour...Subdominio ESMO Gastrointestinal Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Real World Data and Digital Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Affiliated Journals
/about-esmo/discover-esmo-jour...Subdominio Cancer Treatment Reviews
/about-esmo/discover-esmo-jour...Subdominio Clinical Lymphoma Myeloma and Leukemia
/about-esmo/discover-esmo-jour...Subdominio Lung Cancer
/about-esmo/discover-esmo-jour...Subdominio The Breast
/about-esmo/discover-esmo-jour...Subdominio COVID-19 and cancer care in the ESMO journals
/about-esmo/esmo-brandSubdominio ESMO Brand
/about-esmo/esmo-brand/esmo-logoSubdominio ESMO Logo
/about-esmo/collaborate-with-esmoSubdominio Collaborate with ESMO
/about-esmo/collaborate-with-e...Subdominio Texto duplicado Frequently Asked Questions
/about-esmo/president-letterSubdominio President Letter
/about-esmo/president-letter/s...Subdominio Stepping into the shoes of a Society with a global footprint
/about-esmo/president-letter/e...Subdominio Embracing a year of strong collaboration and steady progress
/about-esmo/joining-forcesSubdominio Joining Forces
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2024
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2023
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2022
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2021
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2020
/about-esmo/contact-usSubdominio Contact Us
https://www.esmo.org/membershipSubdominio Membership
A-TITLE Membership
/membership/join-esmoSubdominio Join ESMO
/membership/member-benefitsSubdominio Member Benefits
/membership/membership-categor...Subdominio Membership Categories & Annual Fees
/membership/esmo-in-your-countrySubdominio ESMO in Your Country
https://www.esmo.org/guidelinesSubdominio Guidelines
A-TITLE Guidelines
/guidelines/guidelines-by-topicSubdominio Guidelines by topic
/guidelines/guidelines-by-topi...Subdominio Breast Cancer
/guidelines/guidelines-by-topi...Subdominio Cancers of Unknown Primary Site
/guidelines/guidelines-by-topi...Subdominio Endocrine and Neuroendocrine Cancers
/guidelines/guidelines-by-topi...Subdominio Gastrointestinal Cancers
/guidelines/guidelines-by-topi...Subdominio Genitourinary Cancers
/guidelines/guidelines-by-topi...Subdominio Gynaecological Cancers
/guidelines/guidelines-by-topi...Subdominio Haematological Malignancies
/guidelines/guidelines-by-topi...Subdominio Head and Neck Cancers
/guidelines/guidelines-by-topi...Subdominio Hereditary Syndromes
/guidelines/guidelines-by-topi...Subdominio Lung and Chest Tumours
/guidelines/guidelines-by-topi...Subdominio Melanoma and Skin Cancers
/guidelines/guidelines-by-topi...Subdominio Neuro-Oncology
/guidelines/guidelines-by-topi...Subdominio Sarcoma and GIST
/guidelines/guidelines-by-topi...Subdominio Supportive and Palliative Care
/guidelines/guidelines-newsSubdominio Guidelines News
/guidelines/esmo-expert-consen...Subdominio ESMO Expert Consensus Statements
/guidelines/pagaSubdominio Pan-Asian Guidelines Adaptation (PAGA)
/guidelines/esmo-guidelines-me...Subdominio ESMO Guidelines Methodology
/guidelines/esmo-pocket-guidel...Subdominio Pocket Guidelines & Mobile App
/guidelines/esmo-pocket-guidel...Subdominio Translated ESMO Pocket Guidelines
/guidelines/guidelines-slide-setsSubdominio Guidelines Slide Sets
/guidelines/cancer-patient-man...Subdominio Cancer Patient Management During the COVID-19 Pandemic
/guidelines/cancer-patient-man...Subdominio Disclaimer
/guidelines/cancer-patient-man...Subdominio Primary brain tumours in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Renal cell cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Prostate cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gynaecological malignancies: Cervical cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gynaecological malignancies: Endometrial cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Hodgkin lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Indolent B-NHL in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Multiple myeloma in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Head and neck cancers in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Melanoma in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Sarcomas in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Supportive Care in the COVID-19 era
/guidelines/covid-19-palliativ...Subdominio COVID-19 Palliative Care Pathways
/guidelines/q-a-on-covid-19Subdominio Q&A on COVID-19
/guidelines/covid-19-adapted-r...Subdominio COVID-19 adapted recommendations Slide Sets
/guidelines/esmo-mcbsSubdominio ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS sessions at ESMO 2020
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS in Action
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS for Haematological Malignancies
/guidelines/esmo-mcbs/about-th...Subdominio About the ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS for Solid Tumours
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS Online Tutorials
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS Terms of Use
/about-esmo-meetingsSubdominio Meetings
A-TITLE Meetings
/meeting-calendarSubdominio Texto duplicado Meeting Calendar
/meeting-calendar/past-meetingsSubdominio Past Meetings
/about-esmo-meetings/esmo-cong...Subdominio ESMO Congresses
/about-esmo-meetings/esmo-virt...Subdominio ESMO Virtual Plenaries
/about-esmo-meetings/esmo-virt...Subdominio Sponsors
/about-esmo-meetings/esmo-academySubdominio ESMO Academy
/about-esmo-meetings/esmo-adva...Subdominio ESMO Advanced Courses
/about-esmo-meetings/esmo-adva...Subdominio FAQs
/about-esmo-meetings/esmo-adva...Subdominio Acknowledgements
/about-esmo-meetings/esmo-adva...Subdominio Testimonials
/about-esmo-meetings/esmo-prec...Subdominio ESMO Preceptorship Courses
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado Acknowledgements
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado FAQs
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/esmo-summitsSubdominio ESMO Summits
/about-esmo-meetings/esmo-summ...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/esmo-cour...Subdominio ESMO Courses in Medical Oncology for Medical Students
/about-esmo-meetings/esmo-cour...Subdominio ESMO Best Student Award
/about-esmo-meetings/esmo-cour...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/eso-esmo-...Subdominio ESO-ESMO Masterclasses
/about-esmo-meetings/esmo-symp...Subdominio ESMO Symposia
/about-esmo-meetings/esmo-coll...Subdominio ESMO Colloquia
/about-esmo-meetings/esmo-webi...Subdominio ESMO Webinar Series
/about-esmo-meetings/workshops...Subdominio Workshops
/about-esmo-meetings/esmo-even...Subdominio ESMO Events App
/about-esmo-meetings/esmo-even...Subdominio How to Use the App
/about-esmo-meetings/esmo-lice...Subdominio ESMO Licensed Events
/career-developmentSubdominio Career Development
A-TITLE Career development
/career-development/oncology-f...Subdominio Oncology Fellowships
/career-development/oncology-f...Subdominio Host Institutes
/career-development/oncology-f...Subdominio Host an ESMO Fellow
/career-development/oncology-f...Subdominio Fellowship Offers
/career-development/oncology-f...Subdominio Benefits for Institutes
/career-development/oncology-f...Subdominio Awardees and Reports
/career-development/oncology-f...Subdominio External Oncology Fellowship Opportunities
/career-development/oncology-f...Subdominio About Oncology Fellowships
/career-development/resilience...Subdominio Texto duplicado Resilience Task Force
/career-development/resilience...Subdominio ESMO Resilience Task Force: Survey Series
/career-development/young-onco...Subdominio Young Oncologists Corner
/career-development/young-onco...Subdominio Young Oncologists Track
/career-development/young-onco...Subdominio YO4YO Virtual Session Series
/career-development/young-onco...Subdominio About Young Oncologists Corner
/career-development/young-onco...Subdominio National Activities
/career-development/young-onco...Subdominio Considering a Career Abroad?
/career-development/esmo-exami...Subdominio ESMO Examination
/career-development/esmo-exami...Subdominio Parallel Sessions
/career-development/esmo-exami...Subdominio Why Sit the ESMO Exam?
/career-development/esmo-exami...Subdominio ESMO Exam Talent Pool
/career-development/esmo-exami...Subdominio Sample Exam Questions Explained
/career-development/esmo-exami...Subdominio Best Exam Award
/career-development/recertific...Subdominio Recertification & CME
/career-development/recertific...Subdominio ESMO-MORA Recertification Process and Requirements
/career-development/recertific...Subdominio CME Tests for Handbooks
/career-development/esmo-certi...Subdominio ESMO Certificate of Professional Development
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Advanced Courses
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Preceptorship Courses
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Virtual Plenaries
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Webinar Series
/career-development/jobs-in-on...Subdominio Jobs in Oncology
/career-development/women-for-...Subdominio Women for Oncology
/career-development/women-for-...Subdominio ESMO W4O Observatory
/career-development/women-for-...Subdominio W4O Hub
/career-development/women-for-...Subdominio Resource Centre
/career-development/women-for-...Subdominio W4O Sessions and Events
/career-development/leaders-ge...Subdominio Leaders Generation Programme
/career-development/leaders-ge...Subdominio Class of 2021-2022
/career-development/leaders-ge...Subdominio Class of 2016
/career-development/leaders-ge...Subdominio Class of 2017
/career-development/leaders-ge...Subdominio Class of 2018
/career-development/leaders-ge...Subdominio Class of 2019
/career-development/leaders-ge...Subdominio Leaders Generation Programme Asia
/career-development/leaders-ge...Subdominio Texto duplicado Class of 2019
/career-development/leaders-ge...Subdominio Class of 2022
/career-development/travel-gra...Subdominio Travel Grants for ESMO Meetings
/career-development/about-care...Subdominio About Career Development
/scales-and-toolsSubdominio Scales and Tools
A-TITLE Scales and Tools
/scales-and-tools/esmo-guidanc...Subdominio ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW)
/scales-and-tools/esmo-scale-f...Subdominio ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
/scales-and-tools/esmo-mcbsSubdominio Texto duplicado ESMO-MCBS
https://www.esmo.org/researchSubdominio Research
A-TITLE Research
/research/about-the-grant-schemesSubdominio About the Grant Schemes
/research/esmo-clinical-resear...Subdominio Texto duplicado ESMO Clinical Research Observatory Task Force (ECRO)
/research/esmo-clinical-resear...Subdominio Acknowledgements: Rationalizing Bureaucracy
/research/esmo-clinical-resear...Subdominio Bibliography on Clinical Trial Procedures
/research/research-funding-opp...Subdominio Research Funding opportunities
/research/research-funding-opp...Subdominio ESMO Webinar: EU Research Opportunities
/research/research-funding-opp...Subdominio How to Apply For EU Grants
/research/research-funding-opp...Subdominio EU Calls for Proposals
/research/research-funding-opp...Subdominio Training and Events
/research/research-funding-opp...Subdominio Regulatory Information
/research/research-funding-opp...Subdominio Other Research Funding Opportunities
/research/research-groups-tool...Subdominio Research Groups, Tools and Database
/research/research-groups-tool...Subdominio General research groups
/research/research-groups-tool...Subdominio Cancer research groups by type
/research/research-groups-tool...Subdominio Databases
/research/research-groups-tool...Subdominio Research tools
/research/registries-studies-a...Subdominio COVID-19 and Cancer: Registries, Studies and Surveys
/research/registries-studies-a...Subdominio ESMO-CoCARE Registry
https://www.esmo.org/for-patientsSubdominio For Patients
A-TITLE Patients
/for-patients/esmo-designated-...Subdominio ESMO Designated Centres of Integrated Oncology and Palliative Care
/for-patients/esmo-designated-...Subdominio Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris
/for-patients/esmo-designated-...Subdominio Texto duplicado Designated Centres Working Group
/for-patients/esmo-designated-...Subdominio Palliative and Supportive Care Sessions at ESMO Congress 2023 Madrid
/for-patients/esmo-designated-...Subdominio 2024 ESMO Designated Centres
/for-patients/esmo-designated-...Subdominio Palliative and Supportive Care Sessions at ESMO Congress 2024 Barcelona
/for-patients/resources-for-ca...Subdominio Resources for Patients with Cancer
/for-patients/cancer-care-duri...Subdominio Cancer Care During the COVID-19 Pandemic
/for-patients/cancer-care-duri...Subdominio Multiple Myeloma
/for-patients/cancer-care-duri...Subdominio Melanoma
/for-patients/cancer-care-duri...Subdominio Sarcoma
/for-patients/cancer-care-duri...Subdominio Krebstherapie während der COVID-19-Pandemie
/for-patients/cancer-care-duri...Subdominio Renal Cell Carcinoma
/for-patients/cancer-care-duri...Subdominio Prostate Cancer
/for-patients/cancer-care-duri...Subdominio Pancreatic Cancer
/for-patients/cancer-care-duri...Subdominio Texto duplicado Lung Cancer
/for-patients/cancer-care-duri...Subdominio Ovarian Cancer
/for-patients/cancer-care-duri...Subdominio Supportive Care Glossary
/for-patients/cancer-care-duri...Subdominio Palliative Care Glossary
/for-patients/cancer-care-duri...Subdominio Gastro-Oesophageal Cancer
/for-patients/cancer-care-duri...Subdominio Hepatocellular Carcinoma
/for-patients/cancer-care-duri...Subdominio Endometrial Cancer
/for-patients/cancer-care-duri...Subdominio Colorectal Cancer
/for-patients/cancer-care-duri...Subdominio Primary Brain Tumour
/for-patients/cancer-care-duri...Subdominio Aggressive Lymphoma Management
/for-patients/cancer-care-duri...Subdominio Texto duplicado Breast Cancer
/for-patients/cancer-care-duri...Subdominio B-cell non-Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdominio Urothelial Bladder Cancer
/for-patients/cancer-care-duri...Subdominio Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdominio Cervical Cancer
/for-patients/cancer-care-duri...Subdominio Traitement du Cancer au Cours de la Pandémie de COVID-19
/for-patients/cancer-care-duri...Subdominio Le Cure per il Cancro Durante la Pandemia da COVID-19
/for-patients/cancer-care-duri...Subdominio Cuidado del cáncer durante la pandemia de COVID-19
/for-patients/cancer-care-duri...Subdominio Glossary
/for-patients/patient-advocate...Subdominio Patient Advocates Working Group
/for-patients/patient-advocate...Subdominio Call for Applications
/for-patients/patient-advocacy...Subdominio Patient Advocacy Track
/for-patients/patient-guidesSubdominio Patient Guides
/for-patients/patient-guides/p...Subdominio Patient Guides by Language
/for-patients/patient-guides/b...Subdominio Bone Health in Cancer
/for-patients/patient-guides/p...Subdominio Immunotherapy Side Effects
/for-patients/patient-guides/s...Subdominio Survivorship
/for-patients/patient-guides/c...Subdominio Cancer Pain Management
/for-patients/patient-guides/p...Subdominio Personalised Cancer Medicine
/for-patients/personalised-med...Subdominio Personalised Medicine Explained
/for-patients/getting-the-most...Subdominio Getting the Most out of Your Oncologist
/for-patients/esmo-patient-eng...Subdominio ESMO Patient Engagement Summit
https://www.esmo.org/policySubdominio Policy
A-TITLE Policy
/policy/esmo-manifestoSubdominio ESMO Manifesto
/policy/policy-newsSubdominio Policy News
/policy/esmo-public-policy-com...Subdominio Public Policy Committee
/policy/patient-advocates-work...Subdominio Texto duplicado Patient Advocates Working Group
/policy/cancer-medicines-commi...Subdominio Texto duplicado Cancer Medicines Committee
/policy/esmo-public-policy-tra...Subdominio ESMO Public Policy Track and Special Sessions
https://www.esmo.org/newsroomSubdominio Newsroom
A-TITLE Newsroom
/newsroom/press-and-media-hubSubdominio Press and Media Hub
https://dailyreporter.esmo.org/Nueva ventana Nofollow Externo Subdominio ESMO Daily Reporter
/oncology-newsSubdominio Oncology News
A-TITLE Oncology News
/newsroom/esmo-society-updatesSubdominio ESMO Society Updates
/membership/join-esmoSubdominio Texto duplicado Become a member
https://www.esmo.org/saml/loginTexto duplicado Login
/meeting-calendar/esmo-immuno-...Subdominio See you in Geneva or online
/meeting-calendar/esmo-immuno-...Subdominio Register now!
/meeting-calendar/esmo-tat-202...Nueva ventana Subdominio IMG-ALT ESMO-TAT-2025-1000x250-Abstracts
/meeting-calendar/esmo-tat-202...Subdominio ESMO Targeted Anticancer Therapies Congress 2025
/meeting-calendar/esmo-tat-202...Subdominio Submit Abstract
/guidelines/esmo-mcbsNueva ventana Subdominio IMG-ALT ESMO-MCBS 1000x1000
/guidelines/esmo-mcbsSubdominio Texto duplicado ESMO-MCBS
/guidelines/esmo-mcbsSubdominio Discover more
https://dailyreporter.esmo.org...Externo Subdominio Redispensing cancer medicines means caring for the environment
https://dailyreporter.esmo.org...Externo Subdominio Translating cancer genome insights into practical clinical tools
https://dailyreporter.esmo.org...Externo Subdominio Studies present a wider application of sequencing techniques for the treatment of cancer
https://dailyreporter.esmo.org...Externo Subdominio Liquid biopsies are quickly evolving beyond ctDNA, but technical challenges remain
https://dailyreporter.esmo.org...Externo Subdominio Data from molecular analyses unveil diverse resistance mechanisms to endocrine therapy in breast cancer
https://dailyreporter.esmo.org...Externo Subdominio Innovation is leading to a comprehensive ‘map’ of tumours
https://dailyreporter.esmo.org...Externo Subdominio Adjuvant immunotherapy continues to confirm its efficacy in melanoma
https://dailyreporter.esmo.org...Externo Subdominio The expanding toolbox for immuno-oncology
https://dailyreporter.esmo.org...Externo Subdominio A c-Met directed antibody-drug conjugate shows preliminary activity in a NSCLC cohort
https://dailyreporter.esmo.org/Nueva ventana Externo Subdominio Read the ESMO Daily Reporter
/for-patients/patient-guides/b...Subdominio Patient Guide on Bone Health in Cancer Now Available Also in Hungarian
/oncology-news/five-fraction-s...Subdominio Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients with Low to Intermediate Risk Localised Prostate Cancer
/policy/policy-news/esmo-recom...Subdominio ESMO Recommendations on Continuity of Care for Patients with Cancer Reflected in the New WHO Europe Strategy for Health Emergency Preparedness
/oncology-news/fda-grants-trad...Subdominio FDA Grants Traditional Approval for Selpercatinib for Medullary Thyroid Cancer with a RET Mutation
/newsroom/esmo-society-updates...Subdominio ESMO Award for Immuno-Oncology 2024 Recipient Announced
/oncology-news/ema-recommends-...Subdominio EMA Recommends Extension of Indications for Ribociclib to Include Use in Patients with Early Breast Cancer
/oncology-news/extended-lympha...Subdominio Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer
/oncology-news/a-short-course-...Subdominio A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer
https://dailyreporter.esmo.org...Externo Subdominio Texto duplicado Redispensing cancer medicines means caring for the environment
https://dailyreporter.esmo.org/Nueva ventana Externo Subdominio Texto duplicado Read the ESMO Daily Reporter
/oncology-newsSubdominio More Oncology News
/newsroom/press-and-media-hub/...Subdominio More Press Releases
/newsroom/esmo-society-updatesSubdominio More Society Updates
/oncology-news/five-fraction-s...Subdominio Texto duplicado Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients with Low to Intermediate Risk Localised Prostate Cancer
/oncology-news/fda-grants-trad...Subdominio Texto duplicado FDA Grants Traditional Approval for Selpercatinib for Medullary Thyroid Cancer with a RET Mutation
/oncology-news/ema-recommends-...Subdominio Texto duplicado EMA Recommends Extension of Indications for Ribociclib to Include Use in Patients with Early Breast Cancer
/oncology-news/extended-lympha...Subdominio Texto duplicado Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer
/oncology-news/a-short-course-...Subdominio Texto duplicado A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer
/oncology-news/nivolumab-plus-...Subdominio Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma
/oncology-news/fda-approves-am...Subdominio FDA Approves Amivantamab-vmjw with Carboplatin and Pemetrexed for Non-Small Cell Lung Cancer with EGFR Exon 19 Deletions or L858R Mutations
/oncology-news/fda-approves-ri...Subdominio FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole Co-pack for Early High-Risk Breast Cancer
/oncology-news/cabozantinib-im...Subdominio Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic or Pancreatic Neuroendocrine Tumours
/oncology-newsSubdominio Texto duplicado More Oncology News
/newsroom/press-and-media-hub/...Subdominio Molecular Analysis for Precision Oncology Congress 2024 London, UK, 16-18 October
/newsroom/press-and-media-hub/...Subdominio Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers
/newsroom/press-and-media-hub/...Subdominio Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease
/newsroom/press-and-media-hub/...Subdominio From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing, the ESMO Congress 2024 Takes a Holistic View of Oncology
/newsroom/press-and-media-hub/...Subdominio ESMO 2024 Press Conference
/newsroom/press-and-media-hub/...Subdominio ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being within the Oncology Workforce
/newsroom/press-and-media-hub/...Subdominio Studies Provide First Evidence That Breastfeeding after Breast Cancer Is Safe
/newsroom/press-and-media-hub/...Subdominio ESMO Congress 2024 Barcelona, Spain, 13-17 September
/newsroom/press-and-media-hub/...Subdominio Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
/newsroom/press-and-media-hub/...Subdominio Texto duplicado More Press Releases
/newsroom/esmo-society-updates...Subdominio Texto duplicado ESMO Award for Immuno-Oncology 2024 Recipient Announced
/newsroom/esmo-society-updates...Subdominio ESMO Congress 2024: Five Days of Science Dissemination and Education
/newsroom/esmo-society-updates...Subdominio 2024 ESMO Fellowship Awardees Announced
/newsroom/esmo-society-updates...Subdominio ESMO Releases a New Framework to Assess the Tumour-Agnostic Potential of Cancer Therapies
/newsroom/esmo-society-updates...Subdominio Recipients of the 2024 ESMO Society Awards
/newsroom/esmo-society-updates...Subdominio ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
/newsroom/esmo-society-updates...Subdominio ESMO Journals Have Maintained Strong Impact Factors
/newsroom/esmo-society-updates...Subdominio New ESMO President 2027-2028 Elected
/newsroom/esmo-society-updates...Subdominio Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
/newsroom/esmo-society-updatesSubdominio Texto duplicado More Society Updates
https://www.esmo.org/guidelinesNueva ventana Subdominio IMG-ALT Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdominio Texto duplicado Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdominio Read the guidelines
/about-esmo-meetings/esmo-prec...Subdominio Preceptorships
/about-esmo-meetings/esmo-cour...Subdominio Courses on Medical Oncology for Medical Students
/about-esmo-meetings/esmo-adva...Subdominio Advanced Courses
/about-esmo-meetings/esmo-summitsSubdominio Summits
/about-esmo/discover-esmo-jour...Nueva ventana Subdominio IMG-ALT ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado ESMO Open
/about-esmo/discover-esmo-jour...Subdominio ESMO IO Tech
/about-esmo/discover-esmo-jour...Subdominio More about Journals
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio IMG-ALT Publications
https://oncologypro.esmo.org/e...Externo Subdominio Texto duplicado Publications
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Essentials for Clinicians
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Handbooks
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Factsheet on Biomarkers
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Visit the Education library
/meeting-calendar/emuc-2024Subdominio IMG-ALT EMUC-2024-1000x1000
/meeting-calendar/emuc-2024Subdominio 16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Lung-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Lung Cancer 2024: Paris
/meeting-calendar/esmo-advance...Subdominio IMG-ALT ESMO-Advanced-Course-on-Deep-Dive-in-CDK4/6-Inhibitors-Data-in-Breast-Cancer-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on Breast Cancer: Filling the Gaps Following Progression on CDK4/6 in Hormone Receptor Positive HER2 Negative Advanced Breast Cancer 202...
/meeting-calendar/esmo-advance...Subdominio IMG-ALT ESMO-Advanced-Courses-on-Pancreatic-Cancer-From-Standard-Treatment-to-Individualization-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on Pancreatic Cancer: From Standard Treatment to Individualization 2024: Barcelona
/meeting-calendar/esmo-advance...Subdominio IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and Genitourinary Cancers 2024: Zurich
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Breast-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Breast Cancer 2024: Singapore
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Gastric-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Gastric Cancer 2024: Singapore
/meeting-calendar/esmo-asia-co...Subdominio IMG-ALT ESMO-ASIA-Congress-2024-1000x1000
/meeting-calendar/esmo-asia-co...Subdominio ESMO Asia Congress 2024
/meeting-calendar/esmo-precept...Subdominio Texto duplicado IMG-ALT ESMO-Preceptorship-Lung-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Non-Small-Cell and Small-Cell Lung Cancer 2024: Singapore
/meeting-calendar/esmo-immuno-...Subdominio IMG-ALT ESMO-Immuno-Oncology-2024-1000x1000
/meeting-calendar/esmo-immuno-...Subdominio ESMO Immuno-Oncology Congress 2024
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Prostate-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Prostate Cancer 2024: Lugano
/meeting-calendar/esmo-resilie...Subdominio IMG-ALT ESMO-Workshop-1000x1000-specific
/meeting-calendar/esmo-resilie...Subdominio ESMO Resilience Task Force Workshop: Leading For Better Mental Health, Well-being And Resilience Of The Oncology Workforce
/meeting-calendarSubdominio Discover all ESMO meetings
https://www.youtube.com/user/E...Externo Subdominio Watch all ESMO videos
/career-development/oncology-f...Subdominio Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
/career-development/oncology-f...Subdominio External Fellowship
/career-development/esmo-exami...Subdominio Texto duplicado ESMO Examination
/career-development/esmo-exami...Subdominio Texto ancla no relevante
Read more
/career-development/oncology-f...Subdominio Thinking of applying for an ESMO Oncology Fellowship?
/career-development/oncology-f...Subdominio Fellowship Programme
/membership/member-benefitsSubdominio Discover member benefits
https://www.esmo.org/terms-of-useSubdominio Terms of Use
/terms-of-use/privacy-policySubdominio Privacy Policy
https://www.esmo.org/about-esmoSubdominio Texto duplicado About ESMO
/about-esmo/contact-usSubdominio Texto duplicado Contact Us
https://esmo.my.site.com/myesm...Externo Subdominio Login to your ESMO account
https://www.twitter.com/myesmoNueva ventana Externo Subdominio Twitter
https://www.facebook.com/esmo.orgNueva ventana Externo Subdominio Facebook
https://www.youtube.com/user/E...Nueva ventana Externo Subdominio Youtube
/rss/feed/esmo-newsSubdominio RSS
https://www.linkedin.com/compa...Nueva ventana Externo Subdominio LinkedIn
https://www.instagram.com/esmo...Nueva ventana Externo Subdominio Instagram
https://www.esmo.org/Texto ancla Sin texto
/terms-of-use/privacy-policyNueva ventana Subdominio Texto duplicado Privacy Policy

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.esmo.org/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
El tiempo de respuesta de la página HTML es excelente: 0,05 segundos, y se sitúa por debajo de los 0,40 segundos.
El tamaño HTML de la página es adecuado: 320 kB.

Cabecera HTTP

NombreValor
content-typetext/html; charset=UTF-8
dateThu, 07 Nov 2024 13:22:30 GMT
content-encodinggzip
x-varnish957951998 954743435
age561
varyAccept-Encoding
cache-controlprivate, no-cache, no-store, must-revalidate
accept-rangesbytes
strict-transport-securitymax-age=16000000; preload;
statuscode200
http_versionHTTP/2

Factores externos

Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 5.268 dominios de referencia.
Esta página recibe un total de 539.250 backlinks.
Esta página recibe backlinks de 4.009 direcciones IP distintas.

Backlinks desde Wikipedia

Descubre más links en la función de búsqueda de Wikipedia

Robots.txt

User-agent: *
Crawl-delay: 5
Disallow: /content/search
Disallow: /search
Disallow: /user/login
Disallow: /user/logout
Disallow: /login
Disallow: /logout
Disallow: /saml/
Disallow: /layout/
Disallow: /nglayouts/ajax/
Disallow: /myesmo/
Disallow: /Function/
Disallow: /Event-Type/
Disallow: /Term/
Disallow: /Promoted-content/
Disallow: /view-news/
Disallow: /resources/
Disallow: /useful-links/
Disallow: /no_cache/
Disallow: /fileadmin/
Disallow: /events/
Disallow: /education-research/
Disallow: /career-grants/
Disallow: /Helpdesk-Categories
Disallow: /ESMO-Members-Forum
Disallow: /Featured-articles
Disallow: /Links
Disallow: /Tests
Disallow: /_deprecated/
Disallow: /_tagging-objects/
Disallow: /_old-structure/
Disallow: /daily_reporter/
Disallow: /living-guidelines/
Disallow: /esp/
Disallow: /attendances/certificate/
Sitemap: https://www.esmo.org/sitemaps/index

User-agent: MJ12bot
Disallow: /

User-agent: AhrefsBot
Disallow: /

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.esmo.org
European Society for Medical Oncology
ESMO is the European Society for Medical Oncology, providing a professional network for its members and working with national societies across Europe.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Oncology81%Check
Medical Oncology79%Check
Society77%Check
European77%Check
European Society77%Check
Medical73%Check
ESMO Oncology67%Check
ESMO Society65%Check
Oncology News62%Check
Precision Oncology62%Check
Mostrar más palabras clave

¡Analiza ya gratis hasta 1.000 páginas de esmo.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses